Literature DB >> 4333251

Ontogenesis of the adrenergic nervous system: functional and pharmacologic implications.

B L Mirkin.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4333251

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


× No keyword cloud information.
  8 in total

1.  Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart.

Authors:  H Tanaka; K Shigenobu
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

2.  Age-related changes in catecholamine metabolites of human urine from birth to adulthood.

Authors:  Y Dalmaz; L Peyrin; L Sann; J Dutruge
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

3.  Plasma catecholamines in foetal and adult sheep.

Authors:  C T Jones; R O Robinson
Journal:  J Physiol       Date:  1975-06       Impact factor: 5.182

4.  Catecholamines in fetal pig plasma and the response to acute hypoxia and chronic fetal decapitation.

Authors:  Alastair A Macdonald; Ben Colenbrander; Dirk H G Versteeg; Alfred Heilhecker; Cees J G Wensing
Journal:  Wilehm Roux Arch Dev Biol       Date:  1984-01

5.  Rate, force and cyclic adenosine 3',5'-monophosphate responses to (--)-adrenaline in neonatal rat heart tissue.

Authors:  T L Au; G A Collins; M J Walker
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

6.  Maturation of responsiveness to cardioactive drugs. Differential effects of acetylcholine, norepinephrine, theophylline, tyramine, glucagon, and dibutyryl cyclic AMP on atrial rate in hearts of fetal mice.

Authors:  K Wildenthal
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

7.  Sex-differences in catecholamine metabolites in human urine during development and at adulthood.

Authors:  Y Dalmaz; L Peyrin
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

Review 8.  Pharmacokinetics in the infant.

Authors:  R L Milsap; W J Jusko
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.